Navi: RELAX ASIA

RELAX ASIA

E-mail Print PDF

A Multi center, randomized, double-blind, placebo controlled phase III study to evaluate the efficacy, safety and tolerability of serelaxin when added to standard therapy in acute heart failure patients.

Status : Ongoing

Sponsor/Support : Novartis

Duration : 2014-2016

Principle Investigator : Associate Prof. Dr. Sazzli Kasim

Co-Investigator/s :Dr. Johan Rizwal Ismail and Dr. Kamal Arshad

Study Manager : Nuaim Hussin

venue : CenTRE, UiTM Sungai Buloh Campus

TOOLS for the researcher

  • Clinical research/trial development
  • Statisticians to consult on study design and analysis
  • Facilitate proposal  submission process
  • Study coordinators
  • Subject recruitment registry
  • Collaboration with Clinical Research Organizations (CRO)s Read more...

FACILITIES for the researcher

  • Consultation rooms
  • Day care centre
  • Patient monitoring
  • Satellite pharmacy
  • On site radiological imaging and specialised tests in various subspecialties eg cardiology, respiratory medicine, gastroenterology
  • Archiving and storage Read more...

TRAINING @ CenTRE

The CenTRE conducts various teaching and training programmes to educate and train researchers in translational research and epidemiology, enabling them to conduct high quality research. This can be in the form of seminars, lectures, workshops or short courses. Read more...

Visitors Counter

Number of visitors since 2010
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday130
mod_vvisit_counterThis week1298
mod_vvisit_counterThis month7207

Today: Aug 24, 2017

Take a survey

How did you hear about Us ?







Results

Staff News

Note Headline.


CenTRE Staff Birtday:
NOV 2016
- FADHLINA AB MAJID
- RASYIDAH SALLEH
- MOHAMMAD NAFIQ ARSHAD